跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APREMILAST STADA 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APREMILAST STADA 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APREMILAST STADA 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Stada Arzneimittel Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 28, 2024
Approval ID
b31de56a683e8e29
Company
Stada Arzneimittel Ag
Type
Standard
Approval Details
Approval Id
b31de56a683e8e29
Drug Cima Aemps Name
APREMILAST STADA 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89902
Holder Company Name
Stada Arzneimittel Ag
Marketing Company Name
Laboratorio Stada S.L.
Holder Company Detail Path
/organization/stada-arzneimittel-ag
Authorization Date
2024-10-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg + 20 mg + 30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Stada Arzneimittel Ag
Company Detail Path
/organization/stada-arzneimittel-ag
Company Information
Pharmaceutical Company Name
STADA Arzneimittel AG
Country Name
Germany
Website
http://www.stada.com
Active Ingredients
APREMILAST
30 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 28, 2024
Approval ID
b31de56a683e8e29
Type
Standard
Back to CIMA-AEMPS Approvals